We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2376:TWSEGiga-Byte Technology Co., Ltd. Analysis

Data as of 2026-03-14 - not real-time

NT$233.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Giga‑Byte is trading at TWD 233, comfortably above its 20‑day SMA (226.9) but still below the 50‑day (234.9) and far under the 200‑day SMA (263.8), indicating short‑term momentum while the longer‑term trend remains bearish. Technical indicators are mixed: the MACD histogram is positive and the MACD signal is bullish, yet the RSI sits at a neutral 53 and the price sits near the resistance zone around TWD 239.5. Valuation appears attractive, with a trailing PE of 13.6 versus an industry average of 33.7 and a dividend yield of 4.29% supported by a payout ratio of 58%, suggesting sustainable income.
Fundamentally, the company posted a 36% revenue growth year‑over‑year, though margins remain thin (gross margin 10.4%, operating margin 4.3%). Strong cash generation (free cash flow ~9.4 B TWD) and a net‑cash balance (cash 42.4 B TWD vs debt 34.4 B TWD) provide a solid financial cushion. The DCF‑derived fair value of roughly TWD 533 implies a 34% upside, reinforcing the case that the stock is currently undervalued despite a 30‑day volatility of 35% and a moderate beta of 0.81.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram and increasing volume
  • Proximity to near‑term resistance around TWD 239.5
  • Attractive dividend yield providing downside protection

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth of 36% and solid cash generation
  • Significant valuation gap (PE well below industry, DCF upside >30%)
  • Sustainable dividend payout with comfortable cash coverage

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term secular tailwinds in AI, data‑center and edge computing
  • Robust balance sheet with net cash position and low leverage
  • Undervalued relative to intrinsic fair value, offering substantial upside

Key Metrics & Analysis

Financial Health

Revenue Growth36.20%
Profit Margin3.62%
P/E Ratio13.6
ROE22.85%
ROA7.84%
Debt/Equity56.23
P/B Ratio2.6
Op. Cash FlowNT$5.1B
Free Cash FlowNT$9.4B
Industry P/E33.7

Technical Analysis

TrendBearish
RSI53.0
SupportNT$206.50
ResistanceNT$239.50
MA 20NT$226.88
MA 50NT$234.85
MA 200NT$263.81
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueNT$532.87
Target PriceNT$312.56
Upside/Downside34.14%
GradeUndervalued
TypeBlend
Dividend Yield4.29%

Risk Assessment

Beta0.81
Volatility34.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.